Obesity-associated focal segmental glomerulosclerosis: pathological features of the lesion and relationship with cardiomegaly and hyperlipidemia - PubMed (original) (raw)
Obesity-associated focal segmental glomerulosclerosis: pathological features of the lesion and relationship with cardiomegaly and hyperlipidemia
R R Verani. Am J Kidney Dis. 1992 Dec.
Abstract
In a review of the autopsies and medical records of 22 obese patients, focal segmental glomerulosclerosis (FSGS) was present in seven. The FSGS was mild in all but one patient. The FSGS of obese patients has similar features to idiopathic FSGS; however, our findings suggest that it lacks the hyperplasia of glomerular epithelial cells, shows no predilection for the corticomedullary junction, and is probably more often seen in the hilar region of the glomeruli. FSGS or glomerulomegaly was not associated with the degree of obesity. We demonstrated lipid deposition in the kidney of obese patients. Obese patients with FSGS, compared to those without FSGS, had higher blood cholesterol (P < 0.10) and higher triglyceride levels (P < 0.01). The mean heart weight of obese patients with FSGS was greater than that of patients without FSGS (P < 0.01). Also, obese patients with FSGS had larger glomeruli (246 +/- 33 microns) than obese patients without FSGS (218 +/- 16 microns) (P < 0.05). These findings suggest that cardiomegaly with hemodynamic changes and glomerular hyperfiltration may play a significant role in the glomerulomegaly and FSGS of obese patients. The secondary or contributory role of lipids in the development of the FSGS of obese patients remains to be determined.
Similar articles
- Focal-segmental glomerulosclerosis. The relationship between tubular atrophy and segmental sclerosis.
Bonsib SM. Bonsib SM. Am J Clin Pathol. 1999 Mar;111(3):343-8. doi: 10.1093/ajcp/111.3.343. Am J Clin Pathol. 1999. PMID: 10078109 - Morphometric study of arterioles and glomeruli in the aging kidney suggests focal loss of autoregulation.
Hill GS, Heudes D, Bariéty J. Hill GS, et al. Kidney Int. 2003 Mar;63(3):1027-36. doi: 10.1046/j.1523-1755.2003.00831.x. Kidney Int. 2003. PMID: 12631084 - Proteinuria, glomerulomegaly and focal glomerulosclerosis in a grossly obese man with obstructive sleep apnea syndrome.
Bailey RR, Lynn KL, Burry AF, Drennan C. Bailey RR, et al. Aust N Z J Med. 1989 Oct;19(5):473-4. doi: 10.1111/j.1445-5994.1989.tb00310.x. Aust N Z J Med. 1989. PMID: 2590100 - Clinicopathological characteristics of obesity-associated focal segmental glomerulosclerosis.
Darouich S, Goucha R, Jaafoura MH, Zekri S, Ben Maiz H, Kheder A. Darouich S, et al. Ultrastruct Pathol. 2011 Aug;35(4):176-82. doi: 10.3109/01913123.2011.584657. Epub 2011 Jun 9. Ultrastruct Pathol. 2011. PMID: 21657818 Review. - Morphologic variants of focal segmental glomerulosclerosis and their significance.
Stokes MB, D'Agati VD. Stokes MB, et al. Adv Chronic Kidney Dis. 2014 Sep;21(5):400-7. doi: 10.1053/j.ackd.2014.02.010. Adv Chronic Kidney Dis. 2014. PMID: 25168828 Review.
Cited by
- Pathology of renal complications in obesity.
Cohen AH. Cohen AH. Curr Hypertens Rep. 1999 Apr-May;1(2):137-9. doi: 10.1007/s11906-999-0008-7. Curr Hypertens Rep. 1999. PMID: 10981055 - Manifestation of renal disease in obesity: pathophysiology of obesity-related dysfunction of the kidney.
D'Elia JA, Roshan B, Maski M, Weinrauch LA. D'Elia JA, et al. Int J Nephrol Renovasc Dis. 2009;2:39-49. doi: 10.2147/ijnrd.s7999. Epub 2009 Nov 6. Int J Nephrol Renovasc Dis. 2009. PMID: 21694920 Free PMC article. - Consequences of morbid obesity on the kidney. Where are we going?
Navarro Díaz M. Navarro Díaz M. Clin Kidney J. 2016 Dec;9(6):782-787. doi: 10.1093/ckj/sfw094. Epub 2016 Sep 20. Clin Kidney J. 2016. PMID: 27994854 Free PMC article. - Emerging global epidemic of obesity: the renal perspective.
Saxena AK. Saxena AK. Ann Saudi Med. 2006 Jul-Aug;26(4):288-95. doi: 10.5144/0256-4947.2006.288. Ann Saudi Med. 2006. PMID: 16883080 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical